Related Experiment Video

Updated: Oct 2, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

369

Reply: Not all HDL particles are equal in idiopathic pulmonary fibrosis

Amisha V Barochia1, Scott D Barnett2, Nargues Weir2

  • 1National Institutes of Health, Laboratory of Asthma and Lung Inflammation, Pulmonary Branch, NHLBI, Bethesda, MD, USA barochiaav@mail.nih.gov.

The European Respiratory Journal
|February 25, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Related Experiment Videos

Last Updated: Oct 2, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

369
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

312
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
312
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.2K

Articles linked to this work by shared authors, journal, and citation graph.

Extended static preservation of donor lungs at 10°C and early post-transplant outcomes: Experience from a center in the US.

JHLT open·2026

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis.

CHEST pulmonary·2026

Pulmonary Veno-Occlusive Disease: A Focused Clinicopathologic Series.

Pulmonary circulation·2026

Effect of different medications on implant complications and success rate: A retrospective study.

The Journal of prosthetic dentistry·2026

Evolving Concepts in Pulmonary Hypertension: Implementation Challenges of the Current Guidelines and Proceedings in the US.

Chest·2026

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.

The New England journal of medicine·2026

The Role of Inflammation in the Pathogenesis of Pulmonary Fibrosis: Mechanisms and Treatment Implications.

The European respiratory journal·2026

YY1 lactylation mediates epithelial barrier dysfunction during acute lung injury.

The European respiratory journal·2026

A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease.

The European respiratory journal·2026

Preclinical models of COPD: a state of the art.

The European respiratory journal·2026

Improved Outcomes with Early Aggressive Therapy in Pediatric Pulmonary Hypertension.

The European respiratory journal·2026

Single Particle Nanothermometry Quantifies Heating in a Plasmonic Trap.

ACS nano·2026

Quantitative assessment of the size and concentration measurement in a novel flow cytometer.

The Review of scientific instruments·2026

Editorial Commentary: Hip Microinstability: From Diagnostic Chaos to Clinical Precision.

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association·2026

Evaluation of the Collection Efficiency of a Wet-Type Electrostatic Precipitator for Aerosolized Influenza A Virus.

Microorganisms·2026

Clinical Utility of Pleural Tissue Debris Incidentally Obtained During Drainage of Pleural Effusion: A Retrospective Cohort Study.

Biomedicines·2026

Distinct localization and potential functions of GPR37 signaling mediated by prosaposin and protectin D1 in the rat pituitary gland.

The Journal of reproduction and development·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us